Channing Global Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Sell |
4,243
-6,069
| -59% | -$2.36M | 1.06% | 21 |
|
|
2025
Q1 | $4.49M | Sell |
10,312
-13
| -0.1% | -$5.65K | 3.05% | 13 |
|
|
2024
Q4 | $3.81M | Buy |
10,325
+3,161
| +44% | +$1.17M | 2.54% | 15 |
|
|
2024
Q3 | $3.73M | Buy |
7,164
+3,258
| +83% | +$1.69M | 3.14% | 10 |
|
|
2024
Q2 | $2.12M | Hold |
3,906
| – | – | 1.77% | 17 |
|
|
2024
Q1 | $2.03M | Sell |
3,906
-19
| -0.5% | -$9.85K | 1.72% | 19 |
|
|
2023
Q4 | $1.85M | Sell |
3,925
-1,057
| -21% | -$498K | 1.44% | 21 |
|
|
2023
Q3 | $2.17M | Buy |
4,982
+731
| +17% | +$318K | 2.11% | 15 |
|
|
2023
Q2 | $1.89M | Sell |
4,251
-61
| -1% | -$27.1K | 1.91% | 17 |
|
|
2023
Q1 | $1.98M | Sell |
4,312
-845
| -16% | -$389K | 2.18% | 18 |
|
|
2022
Q4 | $2.65M | Sell |
5,157
-167
| -3% | -$85.7K | 3.04% | 11 |
|
|
2022
Q3 | $2.42M | Sell |
5,324
-549
| -9% | -$249K | 3.08% | 12 |
|
|
2022
Q2 | $2.83M | Buy |
5,873
+174
| +3% | +$84K | 3.05% | 12 |
|
|
2022
Q1 | $2.8M | Sell |
5,699
-93
| -2% | -$45.7K | 2.71% | 17 |
|
|
2021
Q4 | $2.69M | Buy |
+5,792
| New | +$2.69M | 2.55% | 18 |
|